click below
click below
Normal Size Small Size show me how
Drug profiles
ondansetron, diltiazem, glucagon, nalmefene, vasopressin
| Question | Answer |
|---|---|
| Vasopressin GENERIC NAME | Vasopressin |
| Vasopressin BRAND NAME | Pitressin synthetic |
| Vasopressin CLASS | Antidiuretic hormone |
| Vasopressin MECHANISM OF ACTION | Stimulation of V1 smooth muscle receptors, potent vasoconstrictor when given in high doses. |
| Vasopressin INDICATIONS | Alternate vasopressor to the first or second dose of epinephrine in cardiac arrest, may be useful in cases of vasodilatory shock |
| Vasopressin CONTRAINDICATIONS | Responsive patients with cardiac disease. |
| Vasopressin ADVERSE REACTIONS | Bronchoconstriction, ischemic chest pain, N/V. |
| Vasopressin INCOMPATABILITIES/DRUG INTERACTIONS | None |
| Vasopressin DOSE/ROUTE Adult | 40 unit one time dose IV/IO to replace the first or second dose of epinephrine in cardiac arrest. |
| Vasopressin ONSET OF ACTION | Immediate |
| Vasopressin PEAK EFFECTS | Variable |
| Vasopressin DURATION OF ACTION | Variable |
| Vasopressin AZ DRUG BOX SUPPLY RANGE | 40 units (optional) |
| DILTIAZEM GENERIC NAME | DILTIAZEM |
| DILTIAZEM BRAND NAME | Cardizem |
| DILTIAZEM CLASS | Calcium Channel Blocker, Calcium antagonist |
| DILTIAZEM MECHANISM OF ACTION | Blocks calcium form moving into the heart muscle cell, which prolongs the conduction of electrical impulses through the AV node. |
| DILTIAZEM INDICATIONS | ventricular rate control in rapid a-fib and a-flutter, and for PSVT refractory to adenosine. |
| DILTIAZEM CONTRAINDICATIONS | Hypotension , heart block, heart failure, Beta Blocker Use |
| DILTIAZEM ADVERSE REACTIONS | hypotension, Bradycardia, heart block, chest pain, and Asystole |
| DILTIAZEM INCOMPATABILITIES/DRUG INTERACTIONS | Avoid use in patients with poison- or drug-induced tachycardia. Calcium chloride can be used to prevent the Hypotensive effects of this drug and treat patients with a calcium channel blocker overdose. |
| DILTIAZEM DOSE/ROUTE Adult Dosage Initial | 0.25 mg/kg IV over 2 minutes If response is inadequate, repeat in 15 minutes 0.35 mg/kg over 2 minutes. Maintenance infusion 5.0 to 15 mg/hr |
| DILTIAZEM ONSET OF ACTION | immediately |
| DILTIAZEM PEAK EFFECTS | 2 hours |
| DILTIAZEM DURATION OF ACTION | 6 hours |
| DILTIAZEM AZ DRUG BOX SUPPLY RANGE | 25 mg |
| Glucagon GENERIC NAME | None |
| Glucagon BRAND NAME | Glucagon |
| Glucagon CLASS | Hyperglycemic agent, insulin antagonist |
| Glucagon MECHANISM OF ACTION | Converts glycogen to glucose |
| Glucagon INDICATIONS | hypoglycemia, beta blocker overdose. |
| Glucagon CONTRAINDICATIONS | Hyperglycemia, hypersensitivity |
| Glucagon ADVERSE REACTIONS | N/V tachycardia, hypertension |
| Glucagon INCOMPATABILITIES/DRUG INTERACTIONS | Incompatible in solution with most other substances. |
| Glucagon DOSE/ROUTE Adult Hypoglycemia | 1mg IM. May repeat in 7-10 minutes. |
| Glucagon DOSE/ROUTE Adult, beta blocker overdose | 5mg over 1 min. second dose of 10mg if symptoms of Bradycardia or hypotension recur. |
| Glucagon DOSE/ROUTE Pediatric, hypoglycemia | 0.5-1mg IM. |
| Glucagon ONSET OF ACTION | 1 minute |
| Glucagon PEAK EFFECTS | 30 minutes |
| Glucagon DURATION OF ACTION | Variable |
| Glucagon AZ DRUG BOX SUPPLY RANGE | 2mg. |
| NALMEFENE GENERIC NAME | NALMEFENE HCl |
| NALMEFENE BRAND NAME | Revex |
| NALMEFENE CLASS | narcotic antagonist |
| NALMEFENE MECHANISM OF ACTION | Competitive inhibition at narcotic receptor sites |
| NALMEFENE INDICATIONS | Opioid overdoses when Naloxone is not available |
| NALMEFENE CONTRAINDICATIONS | Hypersensitivity |
| NALMEFENE ADVERSE REACTIONS | Withdrawal symptoms, N/V, diaphoresis, increased heart rate, v-fib, hypotension or hypertension. |
| NALMEFENE INCOMPATABILITIES/DRUG INTERACTIONS | Should not be mixed with other drugs |
| NALMEFENE DOSE/ROUTE Adult Dosage | IV, IM, and SC |
| NALMEFENE ONSET OF ACTION | 2 minutes |
| NALMEFENE PEAK EFFECTS | Variable |
| NALMEFENE DURATION OF ACTION | 8 hours |
| NALMEFENE AZ DRUG BOX SUPPLY RANGE | 4mg optional |
| Ondansetron GENERIC NAME | Ondansetron |
| Ondansetron BRAND NAME | Zofran |
| Ondansetron CLASS | Antiemetic agent |
| Ondansetron MECHANISM OF ACTION | Selectively blocks serotonin 5-HT3 receptors located in the CNS . |
| Ondansetron INDICATIONS | N/V |
| Ondansetron CONTRAINDICATIONS | Hypersensitivity,Use with caution in patients with hepatic impairment |
| Ondansetron ADVERSE REACTIONS | Headache, dizziness, sedation, Chest pain, arrhythmias |
| Ondansetron INCOMPATABILITIES/DRUG INTERACTIONS | Inducers or inhibitors of P450 drug metabolizing enzymes may alter the clearance of Ondansetron. |
| Ondansetron DOSE/ROUTE Adult Dosage | 4 – 8 mg IV slow push over 2 – 5 minutes |
| Ondansetron DOSE/ROUTE Pediatric Dosage | 0.1 mg/kg IV slow push over 2 – 5 minutes max dose 4mg |
| Ondansetron ONSET OF ACTION | 30 minutes |
| Ondansetron PEAK EFFECTS | unknown |
| Ondansetron DURATION OF ACTION | unknown |
| Ondansetron AZ DRUG BOX SUPPLY RANGE | 8mg |